Diabetes . Risk of coronary artery disease, heart failure and atrial fibrillation

被引:0
|
作者
Stratmann, B. [1 ]
Hertrampf, K. [1 ,2 ]
Tschoepe, D. [1 ,2 ]
机构
[1] Ruhr Univ Bochum, Herz & Diabet Zentrum NRW, D-32545 Bad Oeynhausen, Germany
[2] Deutsch Diabet Stiftung, Stiftung Der Herzkranke Diabetiker DHD, Berlin, Germany
来源
DIABETOLOGE | 2013年 / 9卷 / 02期
关键词
HbA(1c); Mortality; Myocardial revascularization; Diabetic cardiomyopathies; Ventricular remodeling; EUROPEAN-SOCIETY; TASK-FORCE; TYPE-2; REVASCULARIZATION; CARDIOMYOPATHY; ASSOCIATION; GUIDELINES; MELLITUS;
D O I
10.1007/s11428-012-0993-z
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Diabetes mellitus is a well-known risk factor for the development of coronary artery disease. The close relationship between metabolic disorders in terms of prediabetes (impaired fasting glucose and impaired glucose tolerance) and heart failure as well as atrial fibrillation is comparable new but not only is diabetes associated with heart diseases the reverse is also true that the diagnosis of diabetes is often made in patients with heart disease. This interplay between metabolism and heart disease needs to be taken into account for diagnostics and therapeutic interventions so that the diabetic heart patient can be treated adequately. A prominent gender-specific effect is described in this scenario which is even more pronounced in this patient cohort suffering from diabetes and heart disease. The main topic of this article is to demonstrate the interrelation and the resulting treatment schedules of these diseases.
引用
收藏
页码:157 / 165
页数:9
相关论文
共 50 条
  • [41] Atrial fibrillation surgery in patients with coronary artery disease
    Deneke, T
    Khargi, K
    Grewe, PH
    Lawo, T
    Kuschkowitz, F
    Calcum, B
    Laczkovics, A
    Mügge, A
    Lemke, B
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (05) : 145A - 145A
  • [42] Anticoagulation in patients with atrial fibrillation and coronary artery disease
    Alkindi, Fahad Abdullah
    Rafie, Ihsan Mahmoud
    HEART VIEWS, 2020, 21 (01): : 32 - 36
  • [43] Antithrombotic Therapy in Atrial Fibrillation and Coronary Artery Disease
    Becker, Richard C.
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (12): : 1169 - 1170
  • [44] The linkage of right coronary artery disease and atrial fibrillation
    Yang, XS
    Sun, JP
    Grimm, RA
    Litovitz, H
    Stewart, WJ
    CIRCULATION, 1996, 94 (08) : 113 - 113
  • [45] Edoxaban for Atrial Fibrillation and Stable Coronary Artery Disease
    Gremmel, Thomas
    NEW ENGLAND JOURNAL OF MEDICINE, 2025, 392 (08): : 826 - 827
  • [46] Heart failure and comorbidities: renal failure, diabetes, atrial fibrillation, and inflammation
    Luescher, Thomas F.
    EUROPEAN HEART JOURNAL, 2015, 36 (23) : 1415 - 1417
  • [47] Atrial fibrillation in coronary artery disease: role of atrial enlargement and ischaemia
    Wang, LX
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2000, 75 (2-3) : 309 - 310
  • [48] Risk stratification in atrial fibrillation and congestive heart failure
    Boriani, G
    Camanini, C
    Branzi, A
    Rapezzi, C
    NEW ADVANCES IN HEART FAILURE AND ATRIAL FIBRILLATION, 2003, : 61 - 64
  • [49] Obesity as a risk factor in atrial fibrillation and heart failure
    Jurica, Jakub
    Pec, Martin Jozef
    Benko, Jakub
    Bolek, Tomas
    Galajda, Peter
    Mokan, Marian
    Samos, Matej
    JOURNAL OF DIABETES AND METABOLIC DISORDERS, 2024, 23 (01) : 125 - 134
  • [50] Atrial Fibrillation and Heart Failure - Identification of Patients at Risk -
    Krummen, David E.
    CIRCULATION JOURNAL, 2016, 80 (03) : 587 - 589